Since reciprocal repression of miR-200c and ZEB1 promotes EMT in several types of cancer cell [15], we hypothesized that CD44s first suppresses expression of miR-200c in SAS-3.4 cells, thereby up-regulating ZEB1. Here, ZEB1 is linked to cancer.